Hepatitis C New D...
Follow
Find
6.3K views | +5 today
Hepatitis C New Drugs Review
FDA approved Incivek(telaprevir, Vertex) on Monday 23 May by its PDUFA deadline.A paradigm shift in the treatment of Hepatitis C virus infection. http://knol.google.com/k/krishan-maggon/boceprevir-merck-telaprevir-vertex/3fy5eowy8suq3/151#
Curated by Krishan Maggon
Your new post is loading...
Your new post is loading...
Scooped by Krishan Maggon
Scoop.it!

Vertex Pharmaceuticals Could See Huge Long-Term Gains - Stocks ...

By Scott Matusow:Vertex Pharmaceuticals (VRTX) engages in the discovery, development, and commercialization of small molecule drugs for the treatment of serious diseases worldwide. Its product pipeline includes ...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Achillion, Idenix could miss hep-C merger bonanza - MarketWatch

Achillion, Idenix could miss hep-C merger bonanzaMarketWatchBy Val Brickates Kennedy, MarketWatch BOSTON (MarketWatch) -- Investors tantalized by a recent string of lucrative takeover offers for hepatitis C drug-developers shouldn't assume that an...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

BB Biotech closes 2011 with a positive performance and confirms upward trend - Reuters

BB Biotech closes 2011 with a positive performance and confirms upward trendReutersVertex reported an impressive market uptake of Incivek, its drug for treating hepatitis C (HCV) patients.
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

HCV New Drug Research: Big Pharma:The Hepatitis C Race For ...

The hepatitis C world saw dramatic upheaval in the past year as researchers learned more about antivirals in development. Vertex won FDA approval in May for its new protease inhibitor, telaprevir (Incivek), which doubled the ...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Achillion's Hepatitis C Pipeline Is A Longshot - Seeking Alpha

Achillion's Hepatitis C Pipeline Is A LongshotSeeking AlphaGilead bought it for its PSI-7797 anti-HCV (Hepatitis C Virus) nucleoside.
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

J&J's hep C drug gets German thumbs up; Ex-Sanofi chemist admits to stealing ... - FiercePharma

J&J's hep C drug gets German thumbs up; Ex-Sanofi chemist admits to stealing ...FiercePharmaStory | Follow @FiercePharma > Germany's drug-review panel concluded that Johnson & Johnson's ($JNJ) hepatitis C drug Incivo beats existing drugs at...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Hepatitis C Drug Sales Soar as Incivek & Victrelis Duke It Out ...

However, because Incivek, also known as telaprevir, costs $49000 wholesale for an entire course of treatment it is beyond the scope of most patients' ability to pay.
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Merck & Co out to lead in hepatitis C - Pharmaceutical and ...

US drugs giant Merck & Co (NYSE: MRK) aims to become a leader in the hepatitis C space, the company's global head of licensing and acquisitions Roger Pomerantz said in an interview with the Bloomberg news service ...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Euphoria from Inhibitex acquisition spreads to other firms - Proactive Investors USA & Canada

Euphoria from Inhibitex acquisition spreads to other firmsProactive Investors USA & CanadaEarlier this year, the FDA approved two pills that offered the first new breakthrough treatments for the liver disease in 20 years.
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Idenix Reports Positive Interim Data For Hep C Drug; Shares Soar - Wall Street Journal

Idenix Reports Positive Interim Data For Hep C Drug; Shares SoarWall Street JournalBiopharmaceutical company Idenix Pharmaceuticals Inc.
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

HCV New Drug Research: All About; Incivek (Telaprevir)-An Oral ...

Telaprevir is an oral NS3/4A protease inhibitor that was recently approved by the Food and Drug Administration for the treatment of chronic hepatitis C virus (HCV) genotype 1 infection in adult patients with compensated liver ...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

FDA New Drug Approvals in 2011 Outpace Recent Past - Genetic Engineering News

FDA New Drug Approvals in 2011 Outpace Recent PastGenetic Engineering NewsTwo drugs for the treatment of hepatitis C won approval in May, 2011—the first new drugs approved for the viral disease in 20 years: Vertex' Incivek (telaprevir) and Roche's...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Idenix Reports Positive Interim Data for Hepatitis C Drug - Wall Street Journal

CitybizlistIdenix Reports Positive Interim Data for Hepatitis C DrugWall Street JournalBy BEN FOX RUBIN Biopharmaceutical company Idenix Pharmaceuticals Inc.
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C ...

The hepatitis C world observed extraordinary upheaval in the earlier yr as scientists learned more about antivirals in growth. Vertex won FDA approval in may for its new protease inhibitor, telaprevir (Incivek), which doubled ...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Reviewing the drug class of 2011 | BIOtechNow

Second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile. 16, 5/23/2011, NME, Incivek, telaprevir, Vertex (JNJ), Novel Hepatitis C drug ...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Research and Markets: Hepatitis C (HCV) Market Forecast & Drugs Pipeline ... - Business Wire (press release)

Research and Markets: Hepatitis C (HCV) Market Forecast & Drugs Pipeline ...Business Wire (press release)DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/f90328/hepatitis_c_hcv) has announced the addition of...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Infectious Disease Medical Article | Safety, pharmacokinetics and resistant variants of telaprevir alone for 12weeks in hepatitis C virus genotype 1b infection

Infectious Disease Medical Article: Safety, pharmacokinetics and resistant variants of telaprevir alone for 12weeks in hepatitis C virus genotype 1b infection (Safety, pharmacokinetics and resistant variants of telaprevir alone for 12weeks in hepatitis...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Scientists show brain vulnerable to Hepatitis C virus - Medical Xpress

Scientists show brain vulnerable to Hepatitis C virusMedical Xpress(Medical Xpress) -- Scientists at the University of Birmingham have demonstrated for the first time that human brain cells can become infected with the Hepatitis C virus (HCV), it...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Bristol-Myers Hepatitis C Pills Clear Virus Without Injections - Bloomberg

Los Angeles TimesBristol-Myers Hepatitis C Pills Clear Virus Without InjectionsBloomberg(BMY) pills cleared the hepatitis C virus in 36 percent of patients not helped by a standard treatment, in a small study testing a new approach against the...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

HCV New Drug Research: A Viral Dynamic Model for Treatment ...

... Varun Garg. 1 Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, United States of America, 2 Johnson & Johnson Pharmaceutical Research and Development, LLC, Raritan, New Jersey, United States of America ....
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Gilead nears completion of Pharmasset deal - BusinessWeek

Gilead nears completion of Pharmasset dealBusinessWeekPharmasset Inc. has three potential hepatitis C treatments in clinical testing, including a candidate labeled PSI-7977 in late-stage testing.
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Merck Hepatitis C Drug May 'Anchor' Future Worldwide Regimen - BusinessWeek

Merck Hepatitis C Drug May 'Anchor' Future Worldwide RegimenBusinessWeekThe company's pill and Vertex Pharmaceuticals Inc.'s Incivek, cleared for sale just 10 days after Victrelis, are easier to use and have fewer side effects than the standard...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Presidio Pharmaceuticals Reports Progress with Hepatitis C Antiviral Programs - Business Wire (press release)

Presidio Pharmaceuticals Reports Progress with Hepatitis C Antiviral ProgramsBusiness Wire (press release)Dosing of the first cohort of hepatitis C patients will begin this week.
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Bristol ups hepatitis C game in $2.5B acquisition - seattlepi.com

NEW YORK (AP) — Looking to angle in an a market that is growing fast, Bristol-Myers will spend $2.5 billion to acquire hepatitis C drug developer Inhibitex Inc., which saw its share price double in one day recently on early stage data of a ...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Pharma giants buy up hepatitis C hopefuls - Nature.com (blog)

Pharma giants buy up hepatitis C hopefulsNature.com (blog)For more on HCV treatments, see Nature's article 'New drug targets raise hopes for hepatitis C cure' and the more detailed (but not free) pipeline update in Nature Reviews Drug Discovery...
more...
No comment yet.